Profile picture

Mrs Maria Juana Oyanguren Artola

BIOCRUCES Health Research Institute, Bilbao (Spain)
Follow
Logo ESC

Contributor content

Diferencias de género en la titulación de fármacos de pacientes con insuficiencia cardiaca y fracción de eyección reducida del ensayo ETIFIC.
Presentation
Diferencias de género en la titulación de fármacos de pacientes con insuficiencia cardiaca y fracción de eyección reducida del ensayo ETIFIC.
Read more
Heart failure patients with reduced left ventricular ejection fraction, who reached 100% target dose of beta-blockers in randomized and observational studies
Presentation
Heart failure patients with reduced left ventricular ejection fraction, who reached 100% target dose of beta-blockers in randomized and observational studies
Read more
Prevalence of depression and anxiety in "de novo" heart failure patients with reduced left ventricular ejection fraction and related factors
Presentation
Prevalence of depression and anxiety in "de novo" heart failure patients with reduced left ventricular ejection fraction and related factors
Read more
Clinical, psychosocial and quality of life profile of hospitalized patients with de novo heart failure and reduced left ventricular ejection fraction, etific project
Presentation
Clinical, psychosocial and quality of life profile of hospitalized patients with de novo heart failure and reduced left ventricular ejection fraction, etific project
Read more

ESC 365 is supported by

novartis Explore sponsored resources